Search research articles
Contact Us
Filters
Showing results (431-440 of 442) with videos related to
Page
of 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2019
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G Majzner, Johanna L Theruvath, Anandani Nellan, et al.
Cancer Cell
|
September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Cell Reports
|
November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
Yang Feng, Jaewon Lee, Liping Yang, et al.
Cell Reports. Medicine
|
September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma
Meijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Iscience
|
July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2022
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
Yunji Liao, Hang Ma, Zhenyu Wang, et al.
Mabs
|
December 31, 2015
The INNs and outs of antibody nonproprietary names
Tim D Jones, Paul J Carter, Andreas Plückthun, et al.
Cancer Discovery
|
May 22, 2021
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
Hai-Feng Zhang, Christopher S Hughes, Wei Li, et al.
Cancer Discovery
|
April 13, 2026
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers
Hai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang, et al.
Page
of 45
Search research articles
Search
Showing results (431-440 of 442) with videos related to
Sort By:
Page
of 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2019
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G Majzner, Johanna L Theruvath, Anandani Nellan, et al.
Cancer Cell
|
September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Cell Reports
|
November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
Yang Feng, Jaewon Lee, Liping Yang, et al.
Cell Reports. Medicine
|
September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma
Meijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Iscience
|
July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2022
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
Yunji Liao, Hang Ma, Zhenyu Wang, et al.
Mabs
|
December 31, 2015
The INNs and outs of antibody nonproprietary names
Tim D Jones, Paul J Carter, Andreas Plückthun, et al.
Cancer Discovery
|
May 22, 2021
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
Hai-Feng Zhang, Christopher S Hughes, Wei Li, et al.
Cancer Discovery
|
April 13, 2026
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers
Hai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang, et al.
Page
of 45